Quick Order Cart

Cat. No. ARG43806

Cybb Knockout RAW 264.7 Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Mus musculus (Mouse)

  • Tissue Source:

    Ascites

  • Disease:

    Leukemia

The Cybb Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited mouse macrophage cell line with targeted disruption of the Cybb gene, which encodes the catalytic NOX2 (gp91phox) subunit of phagocyte NADPH oxidase. This knockout model eliminates the respiratory burst and redox signaling mediated by superoxide and hydrogen peroxide, with key interacting partners including p22phox, p47phox, and Rac GTPases. Derived from the RAW 264.7 monocyte/macrophage line, it is ideal for studying chronic granulomatous disease (CGD), host-pathogen interactions, and ROS-dependent pathways. Applications include ROS detection, phagocytosis and killing assays, cytokine profiling, and screening of NOX2 inhibitors.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    RAW 264.7

    Sex of Donor

    Male

    Age

    Adult

    Derived From Site

    In situ; Ascites

    Gene Name

    CYBB

    Gene Identifier

    NCBI Gene ID 13058

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

Cybb Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the mouse RAW 264.7 macrophage line, engineered for targeted disruption of the Cybb gene. This genetic modification eliminates functional expression of gp91phox (NOX2), the catalytic subunit of phagocyte NADPH oxidase. The cell line provides a defined loss-of-function model for investigating NOX2-dependent processes without confounding variables from pharmacological inhibition.

RAW 264.7 is a widely used mouse leukemic monocyte/macrophage cell line capable of phagocytosis, cytokine production, and antigen presentation, key features of innate immune responses. These cells respond to Toll-like receptor ligands, Fc receptor engagement, and inflammatory cytokines, making them suitable for studying macrophage signaling pathways. The cell line’s robustness and well-characterized responses to stimuli such as LPS and IFN-?? facilitate reproducible experimental systems.

Cybb encodes gp91phox, the catalytic core of the NOX2 enzyme complex. This complex, assembled with regulatory subunits including p22phox (Cyba), p47phox (Ncf1), p67phox (Ncf2), p40phox (Ncf4), and Rac GTPases, catalyzes the transfer of electrons from NADPH to molecular oxygen, generating superoxide anion. Subsequent dismutation yields hydrogen peroxide, which can be further converted by myeloperoxidase to hypochlorous acid. Upstream activators such as IFN-??, GM-CSF, LPS, TNF-??, and phorbol esters trigger complex assembly and enzyme activation via pathways involving TLR4, Fc?? receptors, and protein kinase C. Downstream effects include activation of redox-sensitive transcription factors NF-??B and AP-1, and production of pro-inflammatory cytokines. Thus, Cybb knockout disrupts both the direct microbicidal respiratory burst and redox-dependent signal transduction.

In RAW 264.7 macrophages, Cybb disruption models X-linked chronic granulomatous disease (CGD), characterized by defective superoxide production and impaired killing of bacteria and fungi. This cell line enables dissection of NOX2 contributions to phagocytosis, intracellular killing, and cytokine responses without the compensatory adaptations seen in whole-organism knockouts. It also allows investigation of non-phagosomal ROS signaling roles of NOX2 in macrophage polarization and inflammatory gene expression.

Typical uses include functional analysis of NOX2 in macrophage biology, host-pathogen interaction studies with bacterial and fungal pathogens, screening of NADPH oxidase inhibitors, and examination of ROS-dependent signaling pathways. Representative assays compatible with this model include luminol-enhanced chemiluminescence for total ROS, DHE fluorescence for superoxide, flow cytometric measurement of respiratory burst using dihydrorhodamine 123, western blotting for gp91phox, phagocytosis and bacterial killing assays, cytokine ELISAs, and NF-??B luciferase reporter gene assays. For further technical details or to request this product, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)